Your browser doesn't support javascript.
loading
Survival Outcomes According to TIMP1 and EGFR Expression in Heavily Treated Patients with Advanced Non-small Cell Lung Cancer who Received Biweekly Irinotecan Plus Bevacizumab.
Wills, Beatriz; Cardona, Andrés F; Rojas, Leonardo; Ruiz-Patiño, Alejandro; Arrieta, Oscar; Reguart, Noemí; Carranza, Hernán; Vargas, Carlos; Otero, Jorge; Corrales, Luis; Martín, Claudio; Cuello, Mauricio; Pino, Luis Eduardo; Rolfo, Christian; Rosell, Rafael; Zatarain-Barrón, Zyanya Lucia.
Afiliação
  • Wills B; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogota, Colombia.
  • Cardona AF; Internal Medicine Department, Johns Hopkins University, Baltimore, MD, U.S.A.
  • Rojas L; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogota, Colombia andres.cardona@clinicadelcountry.com a_cardonaz@yahoo.com.
  • Ruiz-Patiño A; Clinical and Translational Oncology Group, Institute of Oncology, Clínica del Country, Bogota, Colombia.
  • Arrieta O; Research Department, University of Bosque, Bogota, Colombia.
  • Reguart N; Oncology Department, Javeriana Oncology Center, San Ignacio Hospital, Bogota, Colombia.
  • Carranza H; Faculty of Medicine, Javeriana University, Bogotá, Colombia.
  • Vargas C; Faculty of Medicine, Javeriana University, Bogotá, Colombia.
  • Otero J; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.
  • Corrales L; Medical Oncology Department, Hospital Clínic, Barcelona, Spain.
  • Martín C; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogota, Colombia.
  • Cuello M; Clinical and Translational Oncology Group, Institute of Oncology, Clínica del Country, Bogota, Colombia.
  • Pino LE; Research Department, University of Bosque, Bogota, Colombia.
  • Rolfo C; Foundation for Clinical and Applied Cancer Research (FICMAC), Bogota, Colombia.
  • Rosell R; Clinical and Translational Oncology Group, Institute of Oncology, Clínica del Country, Bogota, Colombia.
  • Zatarain-Barrón ZL; Research Department, University of Bosque, Bogota, Colombia.
Anticancer Res ; 37(11): 6429-6436, 2017 11.
Article em En | MEDLINE | ID: mdl-29061829
Assuntos
Palavras-chave
Buscar no Google
Adicionar na Minha BVS
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Camptotecina / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Inibidor Tecidual de Metaloproteinase-1 / Receptores ErbB / Bevacizumab / Neoplasias Pulmonares Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Anticancer Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Grécia
Buscar no Google
Adicionar na Minha BVS
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Camptotecina / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Inibidor Tecidual de Metaloproteinase-1 / Receptores ErbB / Bevacizumab / Neoplasias Pulmonares Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Anticancer Res Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Colômbia País de publicação: Grécia